US Broker Ratings

Vera Therapeutics, Inc. (VERA) Investor Outlook: Exploring a 141% Upside Potential

Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company, is capturing investor attention with its promising development pipeline and a substantial potential upside of 141.09%, according..

Artivion, Inc. (AORT) Stock Analysis: Navigating a 15.3% Revenue Growth in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT) is making waves in the healthcare sector, particularly within the medical devices industry. Headquartered in Kennesaw, Georgia, this company is renowned for..

Mesoblast Limited (MESO) Stock Analysis: An Investor’s Guide to a 117% Upside Potential in Biotechnology

Mesoblast Limited (NASDAQ: MESO) stands at a compelling juncture in the biotechnology sector, offering a significant potential upside of 117.26% based on current analyst ratings. This..

MiMedx Group, Inc (MDXG) Stock Analysis: A 62% Potential Upside Beckons Investors

Investors hunting for promising opportunities in the biotechnology sector may want to turn their attention to MiMedx Group, Inc. (MDXG). With a market capitalization of $1.11..

Healthcare Services Group, Inc. (HCSG): Investor Outlook with a 23.04% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands out in the healthcare sector with its specialized focus on providing essential services to medical care facilities across the..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 28% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector with a focus on generic and proprietary pharmaceuticals, is making waves among investors with..

Novavax, Inc. (NVAX) Investor Outlook: Unpacking the 67% Potential Upside Amid Vaccine Innovations

For investors with a keen eye on the biotechnology sector, Novavax, Inc. (NVAX) presents a fascinating case study of potential and volatility. With a market capitalization..

National HealthCare Corporation (NHC) Stock Analysis: Unpacking the Potential of a Healthcare Giant with a 28.70% Revenue Surge

National HealthCare Corporation (NYSE: NHC), a powerhouse in the medical care facilities industry, commands attention with its impressive 28.70% revenue growth. As a key player in..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eye-Catching Revenue Growth and a Promising Upside

Investors eyeing Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) will find a company positioned at the forefront of innovative biopharmaceutical solutions, particularly in the field of eye care...

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Unveiling a 43.71% Potential Upside for Investors

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) has been making waves in the healthcare sector with its cutting-edge medical devices tailored for diabetes management. As a mid-cap..

LifeStance Health Group, Inc. (LFST): Investor Outlook Highlights 69.38% Potential Upside

LifeStance Health Group, Inc. (NASDAQ: LFST) is capturing the attention of investors with a compelling mix of growth potential and strong analyst support, underscored by a..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Strong Growth Potential Amidst Biotech Innovation

Travere Therapeutics, Inc. (NASDAQ: TVTX), a leading player in the biotechnology sector, continues to capture investor attention with its strategic focus on rare kidney and metabolic..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth Challenges with a 14.44% Upside Potential

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector, is navigating a complex landscape in the medical instruments and supplies industry. With a market..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Promising Biotech with 187% Potential Upside

Janux Therapeutics, Inc. (NASDAQ: JANX), a clinical-stage biopharmaceutical company, is capturing investor attention with its innovative approach in the biotechnology sector. Specializing in the development of..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a Potential 34% Upside

Warby Parker Inc. (NYSE: WRBY), a disruptor in the eyewear industry, has been capturing investor attention with its innovative business model and growth potential. As a..

Aurinia Pharmaceuticals (AUPH) Stock Analysis: Strong Revenue Growth Amidst High Investor Ratings

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a prominent player in the biotechnology sector, specializes in developing therapies for autoimmune diseases, particularly lupus nephritis. The company’s flagship product,..

PACS Group, Inc. (PACS) Stock Analysis: Unveiling a 194% Potential Upside in Healthcare Sector

PACS Group, Inc. (PACS), a notable player in the healthcare sector, is capturing investor attention with its remarkable potential upside of 194.03%. This Farmington, Utah-based company..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A 17.9% Potential Upside in the Biotech Arena

Investors looking for promising opportunities in the biotechnology sector should consider Kymera Therapeutics, Inc. (NASDAQ: KYMR). This clinical-stage biopharmaceutical company, headquartered in Watertown, Massachusetts, is making..

Haemonetics Corporation (HAE): Investor Outlook on a Medical Device Innovator with 51.73% Upside Potential

Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices sector, offers investors a compelling opportunity for significant returns. With a current market cap of..

Alvotech (ALVO) Stock Analysis: A Biotech with 224% Upside Potential

Alvotech (NASDAQ: ALVO) is a Luxembourg-based company making waves in the healthcare sector, specifically within the drug manufacturers’ specialty and generic industry. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds